Oropouche Virus Test Introduced by Quest Diagnostics
Quest Diagnostics has launched a new PCR-based diagnostic test for the Oropouche virus, enhancing preparedness for this emerging disease.
Quest Diagnostics has launched a new PCR-based diagnostic test for the Oropouche virus, enhancing preparedness for this emerging disease.
BBI Solutions adds four new antibodies for HIV-1 with plans to expand offerings related to chikungunya virus, Dengue virus, norovirus, and Zika virus.
At the beginning of May, the US Centers for Disease Control and Prevention issued a health advisory to update clinicians about the use of serologic testing for Zika virus among pregnant women.
Previously authorized for emergency use with serum and plasma samples, the assay is now authorized to be used with urine samples, lengthening the time period during which patients can be tested for Zika from 7 days to 14 days following the onset of symptoms.
Read MoreThe patent applications expand the company’s growing intellectual property portfolio, and include an immunoassay system for the detection of antibodies to such pathogens as Zika and other flaviviruses.
Read MoreFDA’s Center for Biologics Evaluation and Research recently issued a revised guidance document to reduce the risk of Zika virus transmission through donated blood and blood components.
Read MoreTo date, CDC has shipped enough material for Florida to conduct 6,300 Zika antibody tests.
Read MoreA molecular diagnostic from Luminex is the latest to receive emergency use authorization to detect Zika virus.
Read MoreThe PCR-based kit is capable of detecting the presence of Zika virus, which can be an earlier indicator of Zika virus infection than anti-Zika antibodies.
Read MoreThe new antibodies do not crossreact with related flaviviruses tested, nor with chikungunya virus.
Read MoreNew assessments of mosquito populations and test results by Florida public health officials suggest there is a risk of continued active transmission.
Read MoreSerological test may be able to return results in about 4 hours, and could be used in commercial and healthcare facility laboratories.
Read MoreThe US Centers for Disease Control and Prevention cautions that widespread Zika infections warrant urgent action to protect pregnant women.
Read MoreBlood centers will use the assay to screen donated blood collected in potential endemic areas of the southern United States.
Read MoreThe diagnostic test from Hologic is now available for use on 
the fully automated Panther system.
Read MoreBased on recombinant virus technology, the new reference material provides a safe, non-replicative, and fully extractable positive material.
Read MoreMore than $85 million in redirected funds identified by the Department of Health and Human Services is being made available to support efforts to protect Americans from Zika infection and associated adverse health outcomes.
Read MoreAltona Diagnostics’ test enables qualitative detection of RNA from Zika virus in persons meeting clinical or epidemiological criteria set by the US Centers for Disease Control and Prevention.
Read More